Key Takeaways
- Rocket Lab’s Q1 2026 earnings release is scheduled for after-hours on May 7
- Market volatility forecast at 13.88% based on options pricing for RKLB stock
- Analysts project revenue around $190.9 million, marking 50%+ annual growth
- Expected loss per share of $0.04–$0.07, significantly better than last year’s -$0.12
- Consensus analyst target ranges from $83.31–$89.00 with a “Moderate Buy” recommendation
Rocket Lab is set to unveil its Q1 2026 financial results following market close on Thursday, May 7, beginning at 5:00 PM ET. Trading near $77 per share, RKLB stock commands a market valuation of approximately $43.9 billion.
Derivatives markets are forecasting a 13.88% price movement in either direction after earnings are announced. This projection substantially exceeds Rocket Lab’s typical 4.65% post-earnings fluctuation observed across the previous four reporting periods.
Analyst consensus points to quarterly revenue near $190.99 million, representing year-over-year expansion exceeding 50%. Earnings forecasts call for a per-share loss between $0.04 and $0.07, showing notable progress compared to the $0.12 deficit recorded during Q1 2025.
Beyond the financial metrics, market participants are particularly focused on developments surrounding the Neutron rocket initiative.
Neutron represents a 43-meter partially reusable launch vehicle engineered for satellite deployment and freight operations. Commercial launches are anticipated in the late 2026 to early 2027 timeframe. Success with Neutron could position Rocket Lab as a legitimate alternative to SpaceX’s Falcon 9 platform.
Profitability Metrics and Contract Pipeline Under Scrutiny
Margin performance will receive considerable attention from analysts. Rocket Lab’s GAAP gross margin reached 34.4% throughout 2025, though sustained improvement remains essential for achieving bottom-line profitability.
The company closed Q4 2025 with an all-time high backlog totaling $1.85 billion. Market watchers are looking for evidence that this pipeline is translating into accelerating revenue recognition.
Executive Transactions and Institutional Positioning
Regarding insider activity, CEO Peter Beck divested 18,857 shares on March 2 at $69.59 each. That same day, CFO Adam Spice liquidated 62,744 shares, generating proceeds of approximately $4.37 million.
Cumulatively, company insiders have offloaded $16.49 million in stock during the last 90-day period. Executive ownership currently represents 8.40% of outstanding shares.
Institutional investors have demonstrated contrary behavior. Alliancebernstein expanded its holdings by 818.8% during Q3. Amundi similarly increased its position by 308.4% in the same quarter.
State Street, Deutsche Bank, and Renaissance Technologies have likewise augmented their stakes. Institutional ownership now accounts for 71.78% of RKLB’s share structure.
From the analyst community, Needham reduced its price objective from $110 to $95 while maintaining a Buy recommendation. Wells Fargo launched coverage with an Equal Weight stance and $60 target. Roth MKM elevated its target from $90 to $100 accompanied by a Buy rating.
Cantor Fitzgerald reaffirmed an Overweight designation with an $85 price target. The average analyst target stands at $83.31, spanning a range from roughly $60 to $100.
RKLB maintains a consensus “Moderate Buy” recommendation from 17 analysts — comprising two Strong Buys, nine Buys, five Holds, and one Sell.
The equity has fluctuated between $20.23 and $99.58 throughout the trailing twelve-month period. Current technical indicators show the 50-day moving average at $72.14 and the 200-day at $68.10.





